Literature DB >> 8273554

Peptides based on the conserved predomain sequence of matrix metalloproteinases inhibit human stromelysin and collagenase.

A C Hanglow1, A Lugo, R Walsky, M Finch-Arietta, L Lusch, M Visnick, N Fotouhi.   

Abstract

Prostromelysin, a member of the family of matrix metalloproteinases, is secreted as a zymogen which is activated after cleavage of the His81-Phe82 bond. The 82 amino acid propeptide that is removed during activation contains 12 amino acids, MRKPRC75GVPDVG, that are highly conserved in all MMPs. We evaluated a series of peptides that span this region for their ability to inhibit stromelysin. The hexapeptide, Ac-RCGVPD, and the pentapeptide, Ac-RCGVP had IC50 values of approx. 10 microM. The tetrapeptide, Ac-RCGV, was somewhat less potent with an IC50 of 60 microM. Smaller peptides, e.g. Ac-RCG, were significantly less potent as inhibitors. Substitutions of Cys75 with Ser resulted in a complete loss of inhibitory activity. The peptides in this series also inhibited human fibroblast collagenase.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8273554     DOI: 10.1007/bf01972749

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  7 in total

1.  Comparison of human stromelysin and collagenase by cloning and sequence analysis.

Authors:  S E Whitham; G Murphy; P Angel; H J Rahmsdorf; B J Smith; A Lyons; T J Harris; J J Reynolds; P Herrlich; A J Docherty
Journal:  Biochem J       Date:  1986-12-15       Impact factor: 3.857

2.  Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate.

Authors:  H Nagase; J J Enghild; K Suzuki; G Salvesen
Journal:  Biochemistry       Date:  1990-06-19       Impact factor: 3.162

3.  Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation.

Authors:  E B Springman; E L Angleton; H Birkedal-Hansen; H E Van Wart
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

4.  Continuously recording fluorescent assays optimized for five human matrix metalloproteinases.

Authors:  S Netzel-Arnett; S K Mallya; H Nagase; H Birkedal-Hansen; H E Van Wart
Journal:  Anal Biochem       Date:  1991-05-15       Impact factor: 3.365

Review 5.  Inhibition of human type IV collagenase by a highly conserved peptide sequence derived from its prosegment.

Authors:  W G Stetler-Stevenson; J A Talano; M E Gallagher; H C Krutzsch; L A Liotta
Journal:  Am J Med Sci       Date:  1991-09       Impact factor: 2.378

6.  Mutational analysis of the transin (rat stromelysin) autoinhibitor region demonstrates a role for residues surrounding the "cysteine switch".

Authors:  A J Park; L M Matrisian; A F Kells; R Pearson; Z Y Yuan; M Navre
Journal:  J Biol Chem       Date:  1991-01-25       Impact factor: 5.157

7.  Purification of rabbit bone inhibitor of collagenase.

Authors:  T E Cawston; W A Galloway; E Mercer; G Murphy; J J Reynolds
Journal:  Biochem J       Date:  1981-04-01       Impact factor: 3.857

  7 in total
  2 in total

1.  Internal cleavages of the autoinhibitory prodomain are required for membrane type 1 matrix metalloproteinase activation, although furin cleavage alone generates inactive proteinase.

Authors:  Vladislav S Golubkov; Piotr Cieplak; Alexei V Chekanov; Boris I Ratnikov; Alexander E Aleshin; Natalya V Golubkova; Tatiana I Postnova; Ilian A Radichev; Dmitri V Rozanov; Wenhong Zhu; Khatereh Motamedchaboki; Alex Y Strongin
Journal:  J Biol Chem       Date:  2010-07-06       Impact factor: 5.157

2.  Fmoc-Sec(Xan)-OH: synthesis and utility of Fmoc selenocysteine SPPS derivatives with acid-labile sidechain protection.

Authors:  Stevenson Flemer
Journal:  J Pept Sci       Date:  2014-12-11       Impact factor: 1.905

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.